Enbrol (etanercept biosimilar)
/ Taj Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 07, 2021
Pembrolizumab-induced cyclic ACTH-dependent Cushing's syndrome treated by a block-and-replace approach with osilodrostat.
(PubMed, Ann Endocrinol (Paris))
- No abstract available
Journal • Endocrine Disorders
1 to 1
Of
1
Go to page
1